Posted Feb. 14, 2013 at 8:33 a.m.

Premium Lock OxyBio strikes supply, manufacturing deal for skin product

Published: 2013-02-14 08:33:00
Updated: 2013-02-14 08:33:00

Oxygen Biotherapeutics

Oxygen Biotherapeutics (Nasdaq: OXBT) has struck a new supply agreement and distribution agreement with a Swiss firm that will make the company’s cosmetic skin product Dermacyte....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders